# Mucormycosis in COVID-19

> **NCT04935463** · — · COMPLETED · sponsor: **Montefiore Medical Center** · enrollment: 728 (actual)

## Conditions studied

- Covid19
- Mucormycosis
- Aspergillosis
- Candida Infection

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04935463
- **Lead sponsor:** Montefiore Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-24
- **Primary completion:** 2022-03-01
- **Final completion:** 2022-03-01
- **Target enrollment:** 728 (ACTUAL)
- **Last updated:** 2023-04-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04935463

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04935463, "Mucormycosis in COVID-19". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04935463. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*